Information From Lank

Establishment Labs Announces Participation in the Stephens Once-a-year Financial commitment Conference

SANTA BARBARA, Calif.–(Company WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global professional medical technological innovation organization committed to improving upon women’s health and fitness and wellness, principally in breast aesthetics and reconstruction, right now announced that Juan José Chacón-Quirós, Founder and Main Govt Officer, and Raj Denhoy, Interim Main Economical Officer and Head of Method and Trader Relations, will participate in the Stephens Annual Investment Convention, which is staying held December 1-3, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to converse in-individual to meeting attendees at 1:00 pm CT on Thursday, December 2, 2021.

A reside webcast of the presentation will be out there to all interested get-togethers on the Establishment Labs investor relations internet site at https://buyers.establishmentlabs.com/. An archived variation of the webcast will be obtainable on the same website adhering to the completion of the event.

About Institution Labs

Establishment Labs Holdings Inc. is a world medical engineering company committed to bettering women’s well being and wellness. The company’s original focus is breast overall health, principally breast aesthetics and reconstruction. Institution Labs presents a portfolio of superior silicone gel-filled breast implants, branded as Motiva Implants® that contain a quantity of progressive and patented functions built to supply enhanced aesthetic and medical outcomes. Considering that professional start in 2010, far more than 1.8 million Motiva Implants® have been sent to plastic surgeons in above 80 nations around the world. The firm also presents or has below progress a number of related solutions and systems, including the Motiva Flora® tissue expander and Motiva MIA®, the company’s minimally invasive breast improvement method. In 2018, Institution Labs acquired an investigational gadget exemption (IDE) from the Food and drug administration for the Motiva Implant® and commenced a medical demo to support regulatory acceptance in the United States. Motiva Implants® are manufactured at the company’s two services in Costa Rica, which are compliant with all applicable regulatory requirements less than ISO13485:2016 and Fda 21 CFR 820 less than the MDSAP application. Please stop by our internet site for additional information at www.establishmentlabs.com.

See also  Maria Sharapova calls for fairness stake in monetary dedication platform Normal public.com